Research map: Real-world evaluation of the effectiveness and safety of tirzepatide in patients with obesity: a prospective study.

Back to the article

Papers in this map

  1. The Metabolic Phenotype in Obesity: Fat Mass, Body Fat Distribution, and Adipose Tissue Function · Gijs H. Goossens · 2017 · 8505 citations · Cited by this paper
  2. Mediterranean versus Western diet: Effects on gut microbiota, systemic inflammation, and clinical implications in metabolic health · 2026 · Related
  3. Once-Weekly Semaglutide in Adults with Overweight or Obesity · John P.H. Wilding · 2021 · 5054 citations · Cited by this paper
  4. Preoperative nutritional risk predicts postoperative complications but not delirium: Evidence from a multicentre surgical cohort · 2026 · Related
  5. The incidence of co-morbidities related to obesity and overweight: A systematic review and meta-analysis · Daphne P. Guh · 2009 · 3911 citations · Cited by this paper
  6. Beyond the wheel of five: Micronutrient contributions of foods not meeting product-level composition criteria on micronutrient intake · 2026 · Related
  7. Tirzepatide Once Weekly for the Treatment of Obesity · Ania M. Jastreboff · 2022 · 3661 citations · Cited by this paper
  8. Plasma metabolomics combined with machine learning for postoperative prognostic stratification in hormone receptor-positive/human epidermal growth factor receptor 2-negative early breast cancer · 2026 · Related
  9. Cardiovascular Effects of Intensive Lifestyle Intervention in Type 2 Diabetes · The Look AHEAD Research Group · 2013 · 2942 citations · Cited by this paper
  10. A fat chance at neuroprotection: Ketogenic diet and Parkinson's disease · 2026 · Related
  11. Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents · Emanuele Di Angelantonio · 2016 · 2875 citations · Cited by this paper
  12. Muscle quality is associated with health-related quality of life in patients with eating disorders · 2026 · Related
  13. A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management · Xavier Pi-Sunyer · 2015 · 2707 citations · Cited by this paper
  14. Real-time prediction of rapid weight change in children with cystic fibrosis who have initiated modulator therapy · 2026 · Related
  15. Obesity in adults: a clinical practice guideline · Sean Wharton · 2020 · 1507 citations · Cited by this paper
  16. Integrating micronutrient assessment into the malnutrition-based chronic disease (MBCD) model: A necessary refinement · 2026 · Related
  17. Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of the DiRECT open-label, cluster-randomised trial · Michael E. J. Lean · 2019 · 975 citations · Cited by this paper
  18. Associations of neutrophil-to-lymphocyte, monocyte-to-lymphocyte, and platelet-to-lymphocyte ratios with cancer incidence in type 2 diabetes · 2026 · Related
  19. Weight Loss and Improvement in Comorbidity: Differences at 5%, 10%, 15%, and Over · Donna H. Ryan · 2017 · 842 citations · Cited by this paper
  20. Genetically predicted breastfeeding propensity and brain microstructural morphology: Insights from genome-wide association study summary statistics and neurogenomics · 2026 · Related
  21. Association of the magnitude of weight loss and changes in physical fitness with long-term cardiovascular disease outcomes in overweight or obese people with type 2 diabetes: a post-hoc analysis of the Look AHEAD randomised clinical trial · Edward Gregg · 2016 · 743 citations · Cited by this paper
  22. Obesity Pathogenesis: An Endocrine Society Scientific Statement · Michael W. Schwartz · 2017 · 731 citations · Cited by this paper
  23. A new framework for the diagnosis, staging and management of obesity in adults · Luca Busetto · 2024 · 477 citations · Cited by this paper
  24. Tirzepatide for Obesity Treatment and Diabetes Prevention · Ania M. Jastreboff · 2024 · 441 citations · Cited by this paper
  25. The Psychosocial Burden of Obesity · David B. Sarwer · 2016 · 394 citations · Cited by this paper
  26. Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity · Patricia J. Rodriguez · 2024 · 307 citations · Cited by this paper
  27. Advances in the Science, Treatment, and Prevention of the Disease of Obesity: Reflections From a Diabetes Care Editors’ Expert Forum · William T. Cefalu · 2015 · 243 citations · Cited by this paper
  28. Body composition changes during weight reduction with tirzepatide in the SURMOUNT ‐1 study of adults with obesity or overweight · Michelle Look · 2025 · 146 citations · Cited by this paper
  29. Tirzepatide and muscle composition changes in people with type 2 diabetes (SURPASS-3 MRI): a post-hoc analysis of a randomised, open-label, parallel-group, phase 3 trial · Naveed A. Sattar · 2025 · 103 citations · Cited by this paper
  30. A systematic review and meta-analysis of the efficacy and safety of pharmacological treatments for obesity in adults · Barbara M. McGowan · 2025 · 94 citations · Cited by this paper
  31. Framework for the pharmacological treatment of obesity and its complications from the European Association for the Study of Obesity (EASO) · Barbara M. McGowan · 2025 · 71 citations · Cited by this paper
  32. Bridging the gap between GLP1-receptor agonists and cardiovascular outcomes: evidence for the role of tirzepatide · Fatemeh Taktaz · 2024 · 61 citations · Cited by this paper
  33. Association between weight reduction achieved with tirzepatide and quality of life in adults with obesity: Results from the SURMOUNT ‐1 study · Kimberly Anne Gudzune · 2024 · 49 citations · Cited by this paper
  34. Cardiometabolic Parameter Change by Weight Regain on Tirzepatide Withdrawal in Adults With Obesity · Deborah Bade Horn · 2025 · 41 citations · Cited by this paper
  35. Real‐world titration, persistence & weight loss of semaglutide and tirzepatide in an academic obesity clinic · Jason M. Samuels · 2025 · 27 citations · Cited by this paper
  36. An Updated Approach to Antiobesity Pharmacotherapy: Moving Beyond the 5% Weight Loss Goal · Connor Enright · 2023 · 25 citations · Cited by this paper
  37. Real-World Weight Loss Observed With Semaglutide and Tirzepatide in Patients with Overweight or Obesity and Without Type 2 Diabetes (SHAPE) · Carmen D. Ng · 2025 · 20 citations · Cited by this paper
  38. High Body Adiposity Drives Glucose Intolerance and Increases Cardiovascular Risk in Normoglycemic Subjects · Belén Pérez‐Pevida · 2018 · 17 citations · Cited by this paper
  39. Tirzepatide and health‐related quality of life in adults with obesity or overweight: Results from the SURMOUNT ‐3 phase 3 randomized trial · Theresa M. Hunter · 2025 · 17 citations · Cited by this paper

Source: OpenAlex (CC0)